0001827401 2026-08-12 2026-08-12 0001827401 1 2026-08-12 2026-08-12 0001827401 2 2026-08-12 2026-08-12 0001827401 3 2026-08-12 2026-08-12 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001827401 BRIGHT MINDS BIOSCIENCES INC. N/A false false false S-8 BRIGHT MINDS BIOSCIENCES INC. Equity Common Shares, no par value per share (not subject to outstanding awards) true 1972812 80.34 158495716.08 0.0001381 21888.26 Equity Common Shares, no par value per share (subject to outstanding options) true 426000 40.72 17346720.00 0.0001381 2395.58 Equity Common Shares, no par value per share (subject to outstanding restricted share units) true 17000 80.34 1365780.00 0.0001381 188.61 177208216.08 24472.45 0.00 24472.45 Note 1(a): Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act" ), this registration statement covers as indeterminate number of additional Common Shares (as defined below) that may be offered and issued to prevent dilution resulting from share dividends, share splits, reverse share splits, combinations of shares, spin-offs, recapitalizations, mergers or similar capital adjustments as provided in the Common Share Stock Option Plan (the "Option Plan") and the Restricted Share Unit Plan (the "RSU Plan," and together with the Option Plan, the "Plans") of Bright Minds Biosciences Inc. (the "Registrant"). Note 1(b): Represents 1,972,812 common shares, without par value (the "Common Shares") of the Registrant to be issued pursuant to future awards under the Plans. Note 1(c): Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act and based on the average of the high and low prices for the common shares reported on the Nasdaq Capital Market on August 11, 2026, which was $80.34 per share. Note 2(a): Pursuant to Rule 416(a) under the Securities Act, this registration statement covers as indeterminate number of additional Common Shares that may be offered and issued to prevent dilution resulting from share dividends, share splits, reverse share splits, combinations of shares, spin-offs, recapitalizations, mergers or similar capital adjustments as provided in the Option Plan of the Registrant. Note 2(b): Represents 426,000 Common Shares that may be issued upon the exercise of outstanding options granted under the Option Plan. Note 2(c): Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(h) under the Securities Act and based on the weighted average of the exercise price of $40.72 of options granted under the Option Plan outstanding as of August 11, 2026, and a USD/CAD exchange rate of 1.3927 as of August 11, 2026. Note 3(a): Pursuant to Rule 416(a) under the Securities Act, this registration statement covers as indeterminate number of additional Common Shares that may be offered and issued to prevent dilution resulting from share dividends, share splits, reverse share splits, combinations of shares, spin-offs, recapitalizations, mergers or similar capital adjustments as provided in the RSU Plan of the Registrant. Note 3(b): Represents 17,000 Common Shares that may be issued upon the settlement of outstanding restricted share units under the RSU Plan. Note 3(c): Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act and based on the average of the high and low prices for the common shares reported on the Nasdaq Capital Market on August 11, 2026, which was $80.34 per share.